Target
Suppressor of tumorigenicity 14 protein
Ligand
BDBM50017924
Substrate
n/a
Meas. Tech.
ChEMBL_1364433 (CHEMBL3294545)
Ki
116±n/a nM
Citation
 Goswami, RMukherjee, SGhadiyaram, CWohlfahrt, GSistla, RKNagaraj, JSatyam, LKSubbarao, KPalakurthy, RKGopinath, SKrishnamurthy, NRIkonen, TMoilanen, ASubramanya, HSKallio, PRamachandra, M Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy. Bioorg Med Chem 22:3187-203 (2014) [PubMed]  Article 
Target
Name:
Suppressor of tumorigenicity 14 protein
Synonyms:
Epithin | Hepatocyte growth factor activator/Serine protease hepsin/Suppressor of tumorigenicity 14 protein | MT-SP1 | Membrane-type serine protease 1 | PRSS14 | Prostamin | SNC19 | ST14 | ST14_HUMAN | Serine protease TADG-15 | Suppressor of tumorigenicity 14 protein | Suppressor of tumorigenicity protein 14 | TADG15
Type:
Single-pass type II membrane protein
Mol. Mass.:
94769.23
Organism:
Homo sapiens (Human)
Description:
Q9Y5Y6
Residue:
855
Sequence:
MGSDRARKGGGGPKDFGAGLKYNSRHEKVNGLEEGVEFLPVNNVKKVEKHGPGRWVVLAAVLIGLLLVLLGIGFLVWHLQYRDVRVQKVFNGYMRITNENFVDAYENSNSTEFVSLASKVKDALKLLYSGVPFLGPYHKESAVTAFSEGSVIAYYWSEFSIPQHLVEEAERVMAEERVVMLPPRARSLKSFVVTSVVAFPTDSKTVQRTQDNSCSFGLHARGVELMRFTTPGFPDSPYPAHARCQWALRGDADSVLSLTFRSFDLASCDERGSDLVTVYNTLSPMEPHALVQLCGTYPPSYNLTFHSSQNVLLITLITNTERRHPGFEATFFQLPRMSSCGGRLRKAQGTFNSPYYPGHYPPNIDCTWNIEVPNNQHVKVRFKFFYLLEPGVPAGTCPKDYVEINGEKYCGERSQFVVTSNSNKITVRFHSDQSYTDTGFLAEYLSYDSSDPCPGQFTCRTGRCIRKELRCDGWADCTDHSDELNCSCDAGHQFTCKNKFCKPLFWVCDSVNDCGDNSDEQGCSCPAQTFRCSNGKCLSKSQQCNGKDDCGDGSDEASCPKVNVVTCTKHTYRCLNGLCLSKGNPECDGKEDCSDGSDEKDCDCGLRSFTRQARVVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV
  
Inhibitor
Name:
BDBM50017924
Synonyms:
CHEMBL3289044
Type:
Small organic molecule
Emp. Form.:
C29H34N6O4
Mol. Mass.:
530.6181
SMILES:
NCCC(=O)Nc1ccc(Oc2cc(Oc3ccc(cc3)C(N)=N)cc(c2)C(=O)N[C@H]2CC[C@H](N)CC2)cc1 |r,wU:30.31,wD:33.35,(-.16,-9.38,;-.16,-7.84,;1.17,-7.07,;1.17,-5.53,;-.16,-4.76,;2.51,-4.76,;3.84,-5.53,;3.84,-7.07,;5.17,-7.84,;6.51,-7.07,;7.84,-7.84,;9.17,-7.07,;9.17,-5.53,;10.51,-4.76,;10.51,-3.22,;11.84,-2.45,;11.84,-.91,;13.18,-.14,;14.51,-.91,;14.51,-2.45,;13.18,-3.22,;15.84,-.14,;17.18,-.91,;15.84,1.4,;11.84,-5.53,;11.84,-7.07,;10.51,-7.84,;13.18,-7.84,;13.18,-9.38,;14.51,-7.07,;15.84,-7.84,;17.18,-7.07,;18.51,-7.84,;18.51,-9.38,;19.84,-10.15,;17.18,-10.15,;15.84,-9.38,;6.51,-5.53,;5.17,-4.76,)|
Structure:
Search PDB for entries with ligand similarity: